| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exec VP &CFO
1 company
Wolff Henry Ward is an Exec VP &CFO at SANGAMO THERAPEUTICS, INC. Recent SEC Form 4 filings include 0 buys and 19 sells.
Estimated insider holdings value: $37K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $10.00 | $120,000.00 | -2.0% | |
| Jun 10, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $12.21 | $146,558.40 | -2.9% | |
| May 11, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $13.25 | $158,949.40 | -2.9% | |
| Apr 10, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $15.31 | $183,770.82 | -1.9% | |
| Mar 19, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 10,000 | $18.00 | $180,000.00 | -4.7% | |
| Mar 10, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $16.68 | $200,201.20 | -2.8% | |
| Mar 4, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 10,000 | $18.00 | $180,000.00 | -4.6% | |
| Feb 10, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $12.65 | $151,750.49 | -1.9% | |
| Jan 12, 2015 | SGMO Sangamo Therapeutics, Inc | Exec VP &CFO | Sale+OE | 12,000 | $15.87 | $190,450.00 | -2.8% |